Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Management Hierarchy Under Crawford Takes Shape; Alderson Elevated

This article was originally published in The Gray Sheet

Executive Summary

The appointment of Center for Veterinary Medicine Office of Research Director Norris Alderson, PhD, as senior associate commissioner for science indicates that acting Commissioner Lester Crawford, PhD, is preparing for a prolonged tenure as head of FDA

You may also be interested in...



FDA Tags Academic Researcher To Probe Advisory Panel Conflicts Of Interest

A joint conflict-of-interest study by FDA and the University of Maryland will survey attendees at the agency's April Circulatory System Devices Advisory Panel and National Mammography Quality Assurance Advisory Committee meetings, according to the project's primary investigator

FDA Tags Academic Researcher To Probe Advisory Panel Conflicts Of Interest

A joint conflict-of-interest study by FDA and the University of Maryland will survey attendees at the agency's April Circulatory System Devices Advisory Panel and National Mammography Quality Assurance Advisory Committee meetings, according to the project's primary investigator

FDA Commissioner Pool: McClellan Fits Non-Industry Profile; Is That Enough?

White House economic advisor Mark McClellan's viability as the next FDA commissioner hinges on Senate HELP Committee Chairman Edward Kennedy's (D-Mass.) willingness to look beyond the physician's strong ties to the Bush administration

Related Content

UsernamePublicRestriction

Register

OM009163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel